Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark.
BMJ. 2010 Mar 9;340:c1101. doi: 10.1136/bmj.c1101.
To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates.
Randomised, placebo controlled, two by two factorial trial.
Bissau, Guinea-Bissau.
1717 low birthweight neonates born at the national hospital.
Neonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months.
Mortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo.
No interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to "early BCG" versus "no early BCG" was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex).
The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610.
研究维生素 A 补充和卡介苗(BCG)疫苗接种对低出生体重儿的影响。
随机、安慰剂对照、两因素析因试验。
几内亚比绍比绍国立医院。
1717 名出生时体重不足 2.5 千克的低出生体重儿。
体重不足 2.5 千克的新生儿被随机分配接受 25000IU 维生素 A 或安慰剂,以及早期 BCG 疫苗或常规的晚期 BCG 疫苗,并随访至 12 个月龄。
12 个月龄时,与接受安慰剂的婴儿相比,接受维生素 A 补充的婴儿的死亡率,计算为死亡率比(MRR)。
维生素 A 补充与 BCG 疫苗分配之间未观察到交互作用(P=0.73)。出生时给予维生素 A 补充与死亡率无显著相关性:与安慰剂相比,维生素 A 补充的 MRR 为 1.08(95%CI 0.79 至 1.47)。按性别分层显示,维生素 A 补充与性别之间存在显著的交互作用(P=0.046),男孩中维生素 A 补充的 MRR 为 0.74(95%CI 0.45 至 1.22),女孩中为 1.42(95%CI 0.94 至 2.15)。当将这些数据与几内亚比绍正常出生体重儿的补充试验数据相结合时,新生儿维生素 A 补充对死亡率的综合影响估计值为 1.08(95%CI 0.87 至 1.33);男孩为 0.80(95%CI 0.58 至 1.10),女孩为 1.41(95%CI 1.04 至 1.90)(维生素 A 与性别之间的交互作用 P=0.01)。
本试验和正常出生体重儿补充试验的综合结果表明,总体而言,在几内亚比绍实施新生儿维生素 A 补充政策不会带来益处。令人担忧的是,这些试验表明,出生时给予维生素 A 补充对女孩可能有害。以前的研究和未来的试验应调查维生素 A 补充是否具有性别差异效应的可能性。
ClinicalTrials.gov NCT00168610。